Harte Group Expands Global Network to Support Pharmaceutical Companies


Doylestown, Pa.

Harte Group, a global company who manages and represents Functional Service Providers for support of clinical development needs, announced that its growing network of partners has reached 44 companies, employing over 7,900 experienced staff with an average company life of 13 years in business.

Due to a changing landscape within clinical development operations and the market being underserved by the existing full-service CRO model, the Harte Group created a full-service CRO offering - one built by leveraging smaller companies. Many sponsors have been looking for alternatives to support smaller programs in their portfolio, as well as looking for more ways to execute their clinical programs and projects.

"I am excited by the high level of interest in this Functional Services Provider model," said Michael Harte, Founder & President of the Harte Group. Harte mentioned that their team is in active discussions with both large pharma and smaller biotechnology firms.

Related Videos
Greg Ball, Founder, ASAP Process Consulting image credit screen shot from video
Janice Chang, CEO, TransCelerate BioPharma @ video screenshot.
Related Content
© 2024 MJH Life Sciences

All rights reserved.